Walking speed and the risk of type 2 diabetes: a systematic review and meta-analysis.

Alireza Emadi, Ahmad Jayedi, Dagfinn Aune, Mahdieh-Sadat Zargar

Journal: British journal of sports medicine 2024;58(6):334-342

PMID: 38050034

Abstract

OBJECTIVE

To investigate the association between walking speed and the risk of type 2 diabetes.

DESIGN

Systematic review and meta-analysis.

DATA SOURCES

PubMed, Scopus, CENTRAL and Web of Science to 30 May 2023.

ELIGIBILITY CRITERIA FOR SELECTING STUDIES

We included cohort studies that explored the association between walking speed and the risk of type 2 diabetes in adults. We used random-effects meta-analyses to calculate relative risk (RR) and risk difference (RD). We rated the credibility of subgroup differences and the certainty of evidence using the Instrument to assess the Credibility of Effect Modification ANalyses (ICEMAN) and Grading of Recommendations Assessment, Development and Evaluation (GRADE) tools, respectively.

RESULTS

Ten cohort studies were included. Compared with easy/casual walking (<3.2 km/hour), the RR of type 2 diabetes was 0.85 (95% CI 0.70 to 1.00); RD=0.86 (95% CI 1.72 to 0) fewer cases per 100 patients; n=4, GRADE=low) for average/normal walking (3.2-4.8 km/hour), 0.76 (95% CI 0.65 to 0.87); RD=1.38 (95% CI 2.01 to 0.75) fewer cases per 100 patients; n=10, GRADE=low) for fairly brisk walking (4.8-6.4 km/hour) and 0.61 (95% CI 0.49 to 0.73; RD=2.24 (95% CI 2.93 to 1.55) fewer cases per 100 patients; n=6, GRADE=moderate) for brisk/striding walking (>6.4 km/hour). There was no significant or credible difference across subgroups based on adjustment for the total volume of physical activity and time spent walking per day. Dose-response analysis suggested that the risk of type 2 diabetes decreased significantly at a walking speed of 4 km/h and above.

CONCLUSIONS

Low to moderate certainty evidence, mainly from studies with a high risk of bias, suggests that walking at faster speeds is associated with a graded decrease in the risk of type 2 diabetes.

PROSPERO REGISTRATION NUMBER

CRD42023432795.

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.

Address: Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran [email protected].; Clinical Research Development Unit, Kowsar Educational, Research and Therapeutic Hospital, Semnan University of Medical Sciences, Semnan, Iran.; Food Safety Research Center (salt), Semnan University of Medical Sciences, Semnan, Iran.; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.; Department of Nutrition, Oslo New University College, Oslo, Norway.; Department of Research, The Cancer Registry of Norway, Oslo, Norway.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.